PD3-2-8: Phase II Trial of Cetuximab (C225) in Combination with Monthly Carboplatin (Cb) and Weekly Paclitaxel (Pac) in Patients with Advanced NSCLC: Promising Early Results
Authors:
Open Access
- 1 August 2007
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 2 (8) , S465-S466